The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.

FDA proposes removal of common decongestant. The FDA is moving to pull a decongestant from store shelves. By Lesya Feinstein. Published: Nov. 27, 2024 at 10:37 AM EST HUNTINGTON ...

The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants.

FDA proposes ending use of decongestant found in many cold, allergy medicines. An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

FDA officials said an agency review of the available data found ... FDA proposes removing ineffective decongestant found in most cold medicine by Nathaniel Weixel - 11/07/24 2:28 PM ET.

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an ...

The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine. The active ingredient is used in over-the ...

The FDA is now seeking public comments on this proposed order. For now, companies may continue to market drug products containing oral phenylephrine as a nasal decongestant.

The Food and Drug Administration proposed ending the use of a common ingredient in many popular over-the-counter cold and allergy medications because it doesn't actually relieve nasal congestion.